Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor - ERK pathway

Cell Proliferation

Volumn 40, Issue 6, 2007, Pages 921-935

  Zeng, Q ^a   Chen, G G ^a   Vlantis, A C ^a   Van Hasselt, C A ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE D PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; THYROID CANCER; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PHOSPHORYLATION; PROPIONATES; PYRAZOLES; RNA INTERFERENCE; RNA, SMALL INTERFERING; THYROID NEOPLASMS;

EID: 36249026963     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2007.00471.x     Document Type: Article

References (24)

1. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Muramatsu M, Marino M (2005) Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J. Cell. Physiol. 203, 193 201.
2. Alexaki VI, Charalampopoulos I, Kampa M, Nifli AP, Hatzoglou A, Gravanis A, Castanas E (2006) Activation of membrane estrogen receptors induce pro-survival kinases. J. Steroid Biochem. Mol. Biol. 98, 97 110.
3. Chen GG, Liu ZM, Vlantis AC, Tse GM, Leung BC, van Hasselt CA (2004) Heme oxygenase-1 protects against apoptosis induced by tumor necrosis factor-alpha and cycloheximide in papillary thyroid carcinoma cells. J. Cell. Biochem. 92, 1246 1256.
4. Choi IJ, Kim JS, Kim JM, Jung HC, Song IS (2003) Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells. Infect Immun 71, 830 837.
5. Clarke RB (2003) Steroid receptors and proliferation in the human breast. Steroids 68, 789 794.
6. Correa P, Chen VW (1995) Endocrine gland cancer. Cancer 75, 338 352.
7. Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellenbogen BS (2003) Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology 144, 3159 3166.
8. Helguero LA, Faulds MH, Gustafsson JA, Haldosen LA (2005) Estrogen receptors alfa (ERα) and beta (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24, 6605 6616.
9. Hiasa Y, Nishioka H, Kitahori Y, Yane K, Nakaoka S, Ohshima M, Konishi N, Nishii K, Kitamura M, Matsunaga T (1993) Immunohistochemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue. Oncology 50, 132 136.
10. Kossmehl P, Shakibaei M, Cogoli A, Infanger M, Curcio F, Schonberger J, Eilles C, Bauer J, Pickenhahn H, Schulze-Tanzil G, Paul M, Grimm D (2003) Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways. Endocrinology 144, 4172 4179.
11. Kurland JF, Voehringer DW, Meyn RE (2003) The MEK/ERK pathway acts upstream of NF kappa B1 (p50) homodimer activity and Bcl-2 expression in a murine B-cell lymphoma cell line. MEK inhibition restores radiation-induced apoptosis. J. Biol. Chem. 278, 32465 32470.
12. Lazennec G (2006) Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett. 231, 151 157.
13. Lee ML, Chen GG, Vlantis AC, Tse GM, Leung BC, van Hasselt CA (2005) Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl-xL. Cancer J. 11, 113 121.
14. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M (2001) Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J. Clin. Endocrinol. Metab. 86, 1072 1077.
15. Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340, 1801 1811.
16. Ron E, Kleinerman RA, Boice JD Jr., Livolsi VA, Flannery JT, Fraumeni JF Jr. (1987) A population-based case-control study of thyroid cancer. J. Natl. Cancer Inst. 79, 1 12.
17. Rosenthal DS (1998) Changing trends. CA Cancer J. Clin. 48, 3 23.
18. Segev DL, Umbricht C, Zeiger MA (2003) Molecular pathogenesis of thyroid cancer. Surg. Oncol. 12, 69 90.
19. Song RX, Santen RJ (2003) Apoptotic action of estrogen. Apoptosis 8, 55 60.
20. Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS (2002) Antagonists selective for estrogen receptor alpha. Endocrinology 143, 941 947.
21. Trisciuoglio D, Iervolino A, Zupi G, Del Bufalo D (2005) Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol. Biol. Cell 16, 4153 4162.
22. Vicini E, Loiarro M, Di Agostino S, Corallini S, Capolunghi F, Carsetti R, Chieffi P, Geremia R, Stefanini M, Sette C (2006) 17-beta-estradiol elicits genomic and non-genomic responses in mouse male germ cells. J. Cell. Physiol. 206, 238 245.
23. 2+ influx via 1-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 135, 59 72.
24. Zivadinovic D, Watson CS (2005) Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res. 7, R130 R144.